UBC academic Michael Law was quoted in a Globe and Mail story on the proposed new drug agency as part of the federal budget.
“I think there’s a lot to be said for having the agency that reviews the evidence, and has that expertise in-house, to also be doing the negotiations with drug companies in terms of price reductions,” said Law, the Canada Research Chair in access to medicines.